Similarly, in a subset of lung cancers that overexpress PRODH, tumor progression is driven by PRODH-mediated increase in ROS, which acts as signaling molecules stimulating the expression of pro-inflammatory cytokines88. This evidence concerns the gene PRODH and lung carcinoma.